Seouleaguer Co Ltd

Seouleaguer's capital structure is highly leveraged, with a debt-to-equity ratio of 4.21, indicating significant reliance on long-term debt to fund operations. The company's liquidity position is weak, as evidenced by a current ratio of 0.39 and negative free cash flow of -72.24 billion KRW, which is insufficient to cover operating cash outflows. The negative net cash position after subtracting total debt further exacerbates liquidity concerns. Profitability metrics are deeply negative, with a return on equity of -24.46% and a return on assets of -3.86%, both well below the typical thresholds for a viable business in the drug retail sector. The company reported a net loss of 8.74 billion KRW, with operating income also negative at -11.66 billion KRW, indicating operational inefficiencies and cost overruns. The company's revenue is distributed across three segments: Healthcare, MSO, and Other Business. While the Healthcare segment is the primary business, the Other Business segment (mobile accessories) may represent a non-core or underperforming part of the portfolio. No specific revenue concentration data is provided, but the negative gross profit of 542.72 million KRW suggests margin compression across segments. Growth prospects are bleak, with no positive revenue outlook provided. The company's operating cash flow is negative, and capital expenditures of 6.59 billion KRW have not translated into improved operational performance or asset returns. The absence of a clear growth strategy or margin improvement is a red flag for investors. The risk assessment highlights medium liquidity risk and low dilution risk, but the key flag of negative net cash after debt is a critical warning sign. The company's negative earnings and cash flow position suggest a high probability of needing external financing, which could lead to further debt accumulation or equity dilution. The absence of a positive earnings trajectory or cash flow generation increases the risk of insolvency. Recent filings and transcripts indicate a deteriorating financial position, with a last actual EPS of -257.00 KRW. The lack of positive guidance or strategic initiatives in disclosed materials suggests the company is struggling to address its operational and financial challenges.